Arellanes IC; Choe N; Solomon V; He X; Kavin B; Martinez AE; Kono N; Buennagel DP; Hazra N; Kim G; D'Orazio LM; McCleary C; Sagare A; Zlokovic BV; Hodis HN; Mack WJ; Chui HC; Harrington MG; Braskie MN; Schneider LS; Yassine HN, 2020. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.  EBioMedicine 59:102883

Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN, 2020. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.  J Alzheimers Dis 74(3):975-990

Espeland MA; Hayden KM; Lockhart SN; Yassine HN; Hoscheidt S; Yasar S; Luchsinger JA; Neiberg RH; Diaz Brinton R; Carmichael O, 2020. Sex-Related Differences in Brain Volumes and Cerebral Blood Flow Among Overweight and Obese Adults With Type 2 Diabetes: Exploratory Analyses From the Action for Health in Diabetes Brain Magnetic Resonance Imaging Study.  J Gerontol A Biol Sci Med Sci 75(4):771-778

Yassine HN; Finch CE, 2020. APOE Alleles and Diet in Brain Aging and Alzheimer's Disease.  Front Aging Neurosci 12:150

Yassine HN; Anderson A; Brinton R; Carmichael O; Espeland MA; Hoscheidt S; Hugenschmidt CE; Keller JN; Peters A; Pi-Sunyer X, 2020. Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus?  Neurobiol Aging 92:61-72

Hu Y; Meuret C; Go S; Yassine HN; Nedelkov D, 2020. Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid.  J Alzheimers Dis 76(3):883-893

Rawat V; Wang S; Sima J; Bar R; Liraz O; Gundimeda U; Parekh T; Chan J; Johansson JO; Tang C; Chui HC; Harrington MG; Michaelson DM; Yassine HN, 2019. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.  J Neurosci 39(48):9611-9622

Kegulian NC; Ramms B; Horton S; Trenchevska O; Nedelkov D; Graham MJ; Lee RG; Esko JD; Yassine HN; Gordts PLSM, 2019. ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.  Arterioscler Thromb Vasc Biol 39(10):2145-2156

Lee S; Parekh T; King SM; Reed B; Chui HC; Krauss RM; Yassine HN, 2019. Low-Density Lipoprotein Particle Size Subfractions and Cerebral Amyloidosis.  J Alzheimers Dis 68(3):983-990

Yassine HN, 2017. Targeting prodromal Alzheimer's disease: too late for prevention?  Lancet Neurol 16(12):946-947

Yassine HN; Schneider LS, 2017. Lessons from the Multidomain Alzheimer Preventive Trial.  Lancet Neurol 16(8):585-586

Jeffs JW; Ferdosi S; Yassine HN; Borges CR, 2017. Ex vivo instability of glycated albumin: A role for autoxidative glycation.  Arch Biochem Biophys 629:36-42

Mendoza S; Trenchevska O; King SM; Nelson RW; Nedelkov D; Krauss RM; Yassine HN, 2017. Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions.  J Clin Lipidol 11(1):224-233.e2

Yassine HN; Croteau E; Rawat V; Hibbeln JR; Rapoport SI; Cunnane SC; Umhau JC, 2017. DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA.  Alzheimers Res Ther 9(1):23

Yassine HN; Braskie MN; Mack WJ; Castor KJ; Fonteh AN; Schneider LS; Harrington MG; Chui HC, 2017. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.  JAMA Neurol 74(3):339-347

Yassine HN; Trenchevska O; Dong Z; Bashawri Y; Koska J; Reaven PD; Nelson RW; Nedelkov D, 2016. The association of plasma cystatin C proteoforms with diabetic chronic kidney disease.  Proteome Sci 14:7

Yassine HN; Feng Q; Chiang J; Petrosspour LM; Fonteh AN; Chui HC; Harrington MG, 2016. ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.  J Am Heart Assoc 5.

Yassine HN; Feng Q; Azizkhanian I; Rawat V; Castor K; Fonteh AN; Harrington MG; Zheng L; Reed BR; DeCarli C; Jagust WJ; Chui HC, 2016. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.  JAMA Neurol 73(10):1208-1216

Trenchevska O; Yassine HN; Borges CR; Nelson RW; Nedelkov D, 2016. Development of quantitative mass spectrometric immunoassay for serum amyloid A.  Biomarkers 21(8):743-751

Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS, 2016. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.  Alzheimers Res Ther 8:25

Azizkhanian I; Trenchevska O; Bashawri Y; Hu J; Koska J; Reaven PD; Nelson RW; Nedelkov D; Yassine HN, 2016. Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.  J Clin Lipidol 10(4):808-815

Yassine HN; Trenchevska O; Ramrakhiani A; Parekh A; Koska J; Walker RW; Billheimer D; Reaven PD; Yen FT; Nelson RW; Goran MI; Nedelkov D, 2015. The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides.  PLoS One 10(12):e0144138

Kimzey MJ; Kinsky OR; Yassine HN; Tsaprailis G; Stump CS; Monks TJ; Lau SS, 2015. Site specific modification of the human plasma proteome by methylglyoxal.  Toxicol Appl Pharmacol 289(2):155-62

Yassine HN; Trenchevska O; He H; Borges CR; Nedelkov D; Mack W; Kono N; Koska J; Reaven PD; Nelson RW, 2015. Serum amyloid a truncations in type 2 diabetes mellitus.  PLoS One 10(1):e0115320

Yassine HN; Jackson AM; Reaven PD; Nedelkov D; Nelson RW; Lau SS; Borchers CH, 2014. The Application of Multiple Reaction Monitoring to Assess Apo A-I Methionine Oxidations in Diabetes and Cardiovascular Disease.  Transl Proteom 4-5:18-24

Yassine HN; Belopolskaya A; Schall C; Stump CS; Lau SS; Reaven PD, 2014. Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.  Metabolism 63(5):727-34

Yassine HN; Jackson AM; Borges CR; Billheimer D; Koh H; Smith D; Reaven P; Lau SS; Borchers CH, 2014. The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins.  Lipids Health Dis 13:8

Taylor A; Westveld AH; Szkudlinska M; Guruguri P; Annabi E; Patwardhan A; Price TJ; Yassine HN, 2013. The use of metformin is associated with decreased lumbar radiculopathy pain.  J Pain Res 6:755-63

Melemedjian OK; Yassine HN; Shy A; Price TJ, 2013. Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment.  Mol Pain 9:14

Kimzey MJ; Yassine HN; Riepel BM; Tsaprailis G; Monks TJ; Lau SS, 2011. New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism.  Chem Biol Interact 192(1-2):122-8

Yassine HN; Davis-Gorman G; Stump CS; Thomson SS; Peterson J; McDonagh PF, 2010. Effect of glucose or fat challenge on aspirin resistance in diabetes.  Int J Endocrinol 2010:820876

Yassine HN; Davis-Gorman G; Stump CS; Thomson SS; Peterson J; McDonagh PF, 2010. Clinical determinants of aspirin resistance in diabetes.  Diabetes Res Clin Pract 90(1):e19-21

Yassine HN; Marchetti CM; Krishnan RK; Vrobel TR; Gonzalez F; Kirwan JP, 2009. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial.  J Gerontol A Biol Sci Med Sci 64(1):90-5

Publication list retrieved from NCBI using ImpactPubs